Drug therapy for heart failure in children with dilated cardiomyopathy
SUN Hui-chao
LYU Tie-wei
Abstract：Dilated cardiomyopathy(DCM)is a group of cardiomyopathies characterized by enlargement of the left ventricle or both ventricles accompanied by systolic dysfunction,which ranks first in the incidence of cardiomyopathies in pediatric patients,with cardiac enlargement,heart failure,arrhythmia and even embolism as the basic clinical manifestations.Its treatment includes etiologic therapy,drug therapy and surgical therapy,aiming to effectively control heart failure and arrhythmia,prevent sudden death and embolism,and improve the quality of life and survival rate of patients,among which anti-heart-failure drug therapy is the basis of DCM treatment.In this article,we discuss the drug selection and treatment progress of heart failure in DCM children,in order to provide guidance and recommendations for clinical treatment.
Keywords：dilated cardiomyopathyheart failuredrugstreatmentchild
Publication Date：2025-03-06
Online Publishing Date：2025-08-15(First online date of this platform, not the publication date of the document)
Pages：7( 225-231 )